Vertex Pharmaceuticals, Inc. (VRTX)
432.65
-9.05
(-2.05%)
USD |
NASDAQ |
Apr 16, 14:51
Vertex Pharmaceuticals Free Cash Flow : 3.194B for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Gilead Sciences, Inc. | 9.456B |
| Eli Lilly & Co. | 5.964B |
| Amgen, Inc. | 8.10B |
| Moderna, Inc. | -2.075B |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 498.00M |
| Cash from Investing (Quarterly) | -288.10M |
| Cash from Financing (Quarterly) | -77.20M |
| Free Cash Flow Per Share (Quarterly) | 1.361 |
| Free Cash Flow to Equity (Quarterly) | 147.40M |
| Free Cash Flow to Firm (Quarterly) | 351.55M |
| Free Cash Flow Yield | 2.86% |